12 years  ·  $2.6B  ·  Every decision matters.

Intelligence for
Decisions That
Cannot Wait.

Turn evidence, market signals, and scientific data into faster action.

Across drug development, regulatory submissions, formulation, clinical operations, and investment decisions — the organizations that act on better intelligence faster win. DAVAI is the platform that makes that possible.

Live intelligence example
Excipient safety profile: Polysorbate 80 in oral solid dosage
4 min
Time to answer
847
Sources cross-referenced
91/100
Confidence score
Safety signal — FDA FAERS 3 adverse event patterns identified · Evidence-graded · Regulatory-ready
Clinical evidence — 214 trials Cross-referenced simultaneously · Confidence weighted
Patent landscape — USPTO / EPO Freedom to operate flagged · Full lineage attached
In life sciences, the cost of a slow decision is not measured in weeks.
It is measured in years of development, billions of dollars, and patients who wait.
DAVAI  ·  Loyto.ai
The Challenge

The evidence exists.
Acting on it is the problem.

Life sciences organizations generate and consume more data than any other industry. The challenge has never been the data — it has been turning it into a decision fast enough to matter.

01

Evidence is scattered across disconnected systems

Scientific literature, clinical trial registries, regulatory databases, adverse event records, and internal research sit in separate silos. Synthesizing them manually takes months — by which time the landscape has changed.

02

Decisions cannot wait for analysis to catch up

Formulation timelines, regulatory submissions, investment decisions, and BD opportunities all operate under time pressure that manual research cannot match. Being second to a defensible answer is not an option.

03

Every conclusion must be traceable and defensible

In regulated environments, an answer is not enough. Every conclusion must trace to its source — raw data, clinical evidence, regulatory filing — and be audit-ready at the moment it is made, not assembled when asked for.

The Intelligence Layer

Four signal types.
One unified intelligence layer.

DAVAI reasons across your organization's scientific and regulatory data using four distinct intelligence layers — each designed to surface a different kind of decision advantage.

Analytical Signals
Evidence Intelligence
What the scientific record is telling you — synthesized simultaneously across all sources.

DAVAI queries thousands of papers, clinical trials, regulatory filings, and adverse event records simultaneously — returning a confidence-weighted, evidence-graded answer with full provenance. No analyst team can match the breadth or the speed.

Safety profile synthesis Evidence confidence score Adverse event patterns Efficacy signals Regulatory precedent
Forecasting Signals
Pipeline Intelligence
What is likely to happen next in the competitive and regulatory landscape.

DAVAI tracks Phase 3 readouts, FDA label changes, FAERS signals, and patent filings as they happen — alerting your team the moment something relevant changes. Your organization gets advance intelligence, not a post-mortem after competitors have moved.

Phase 3 readout alerts Regulatory change signals FAERS monitoring Competitive pipeline Label change tracking
Knowledge Graph Signals
Relationship Intelligence
Connections across compounds, targets, trials, and entities that no single database reveals.

DAVAI builds and continuously updates a knowledge graph across molecular relationships, clinical evidence chains, patent landscapes, and regulatory filings — surfacing connections invisible to any individual system or analyst team.

Compound relationships Patent linkage Target interaction map Trial cross-reference Entity resolution
Machine Learning Signals
Adaptive Intelligence
Scoring and ranking that improves with every query — specific to your organization's context.

DAVAI's models learn from your organization's own research priorities, therapeutic areas, and decision history — continuously refining relevance scoring, evidence weighting, and signal prioritization to become more precise the longer it runs.

Relevance scoring Evidence weighting Risk stratification Confidence index Priority ranking
Who It Serves

Every decision-maker
across the drug lifecycle.

DAVAI delivers the right intelligence to the right person — in the context of the decision they are making right now.

🔬
CSO / R&D Leadership
Pharma & Biotech
Portfolio-level intelligence across programs — competitive signals, pipeline risks, and evidence gaps surfaced automatically so strategy is built on intelligence, not instinct.
📋
Regulatory Leadership
Pharma & Biotech
Every claim traces to primary evidence in one click. Dossier lineage is always ready — not assembled when the FDA asks a follow-up question during review.
⚗️
Formulation Teams
Pharma & Generic Manufacturers
Excipient safety profiles established in days, not months — across regulatory databases, scientific literature, and adverse event records simultaneously.
🏥
Clinical Operations
Pharma, Biotech & CROs
Site history, enrollment patterns, and safety signals cross-referenced simultaneously — enrollment risks surface before they become critical.
📊
Investors & BD Teams
Biotech Funds & Pharma BD
Pipeline intelligence — clinical evidence strength, competitive positioning, freedom-to-operate, and safety signals — in minutes, not weeks of analyst time. The organization that gets to a defensible thesis first wins the deal.
🔭
Contract Research Organizations
CROs
Evidence synthesis across multiple client programs simultaneously — faster turnaround, higher confidence, full lineage — without scaling headcount to match workload.
🩺
Medical Affairs
Pharma & Biotech
Instant, evidence-graded responses with confidence scores and safety context. Congress briefs generated from the live evidence base. KOL influence mapped from the publication graph.
How It Works

From data to decision.
In minutes, not months.

DAVAI connects to your organization's data alongside public scientific and regulatory sources — and starts delivering intelligence immediately.

1
Ingests your data alongside public sources Internal research, proprietary datasets, and regulatory filings connected alongside scientific literature, clinical registries, and adverse event databases — unified into one reasoning layer.
2
Builds a living knowledge graph Compounds, targets, trials, patents, and regulatory filings are mapped and continuously updated — revealing relationships invisible to any individual database or analyst team.
3
Delivers evidence-graded answers Every response comes with a confidence score, full evidence lineage, and source traceability — so your team acts with confidence, not just information.
4
Monitors continuously — without being asked Living agents watch for Phase 3 readouts, FDA label changes, FAERS signals, and patent filings. Your team is notified the moment something relevant changes — automatically.
Decision outcomes
Speed
Months of research compressed to days
The same evidence. The same regulatory rigor. A fraction of the time. That compression changes what is possible in a development cycle — formulation decisions, regulatory responses, and investment theses that previously took quarters now take days.
Confidence
Every answer traceable to its source
DAVAI does not generate answers — it generates defensible conclusions. Every signal traces to primary evidence. Every decision is audit-ready from the moment it is made, not assembled when the regulator or the board asks for documentation.
Competitive Advantage
First to insight. First to act.
In drug development, BD, and biotech investment, being second to a correct conclusion costs money, market position, and time. DAVAI gives your organization a structural intelligence advantage that compounds with every use.
Why Not a General AI Tool

Built for life sciences.
Not adapted for it.

General AI tools generate answers. DAVAI generates defensible decisions — with the evidence lineage, regulatory context, and domain depth that life sciences requires.

General AI Tools
Understand text. Generate plausible answers from patterns in training data.
No evidence provenance. No traceability to primary source data.
No regulatory framework awareness. Cannot reason within FDA, EMA, or ICH guidelines.
Static knowledge cutoff. Cannot monitor live regulatory or scientific developments.
No domain ontologies. Does not understand molecular relationships, therapeutic areas, or clinical nomenclature at depth.
DAVAI Intelligence
Understands relationships between compounds, targets, trials, and regulatory filings — not just the text describing them.
Full evidence lineage on every conclusion — traceable to primary source in one click.
Regulatory-native reasoning — built within FDA, EMA, and ICH frameworks from the ground up.
Living agents monitor continuously — alerting your team as the scientific and regulatory landscape changes.
Deep domain ontologies — molecular pathways, clinical nomenclature, and therapeutic area knowledge built into the reasoning layer.
Start a Conversation

Tell us about the decision your team cannot make fast enough.

Whether you are in pharma, biotech, regulatory affairs, clinical operations, or investment — if your organization is making high-stakes decisions on incomplete or slow intelligence, we would like to understand your situation.

Sowmya Sridhar
Chief Executive Officer, Loyto.ai
🌐
Start a Conversation →